Paper Details

  1. Home
  2. Paper Details

Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.

Author: ScheyRon, SoubraMahmoud

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Lubiprostone is a drug used to treat irritable bowel syndrome with constipation (IBS-C). It activates chloride channels in the intestines, leading to increased fluid secretion and bowel movements. Lubiprostone has been shown to be effective and well-tolerated in women with IBS-C.
Paper Details　
Original Abstract of the Article :
Irritable bowel syndrome with constipation (IBS-C) affects approximately 5% of the population in western countries. The majority of those afflicted are women. Symptoms are often detrimental to the individual's quality of life and incur high healthcare costs to society. There is no evidence to suppor...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987758/

データ提供：米国国立医学図書館（NLM）

Lubiprostone: A Potential Solution for IBS-C in Women

Irritable bowel syndrome with constipation (IBS-C) affects millions, causing a significant impact on quality of life. This study delves into the use of lubiprostone, a novel medication for IBS-C, primarily focusing on its effectiveness in women. The study explores the mechanism of action of lubiprostone, highlighting its unique approach to stimulating bowel movements without directly affecting intestinal muscle contractions. This detailed analysis is essential for understanding the therapeutic potential of lubiprostone.

Lubiprostone Shows Promise for Women with IBS-C

The study suggests that lubiprostone holds great promise for women experiencing IBS-C. Clinical trials have shown its effectiveness in improving symptoms with minimal side effects. Furthermore, the research highlights the need for additional studies to compare lubiprostone with other pharmacological agents, allowing for a more comprehensive understanding of its position within the therapeutic landscape for IBS-C.

Embrace Lubiprostone as a Potential Solution for IBS-C

This research sheds light on a potential solution for women struggling with IBS-C. While more research is needed, lubiprostone appears to be a safe and effective treatment option. However, it is crucial to consult with a healthcare professional to determine if lubiprostone is the right treatment for you.

Dr. Camel's Conclusion

Like a camel navigating a challenging desert landscape, individuals suffering from IBS-C need reliable solutions. This research provides hope by demonstrating the potential of lubiprostone as a safe and effective treatment option, especially for women. The study urges continued investigation to further explore the therapeutic possibilities of lubiprostone and its place in the treatment of IBS-C.

Date :
  1. Date Completed 2014-06-24
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

24833931

DOI: Digital Object Identifier

PMC3987758

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.